ARCHIVES

Sanofi: Zaltrap Price Reflects Competing Drugs In Second-Line Metastatic Colon Cancer

This article is from The Cancer Letter archive.

Vol. 38 No. 41 | November 1, 2012

Download PDF Visit The Full Archive

Related Articles

Bross Claims New Figures Show High Radiation Risk

February 23, 1979

Pazdur Waxes On Calumet City And Krebiozen; Parkinson Takes Interim CMO Job at Zyngenia

April 27, 2012

IVAX And It’s Portfolio

December 22, 1994

In Brief: Russos of Michigan Move To Fox Chase; Becker Named To Endowed Chair; NCI’s David Byar Dies

August 23, 1991

NCCS Networker Volume 11 Issue 2, Summer 1997

June 13, 1997

NCI AIDS Malignancy Bank Accepts Requests; RFA Available

December 1, 1995